UBS Lux Equity Fund Biotech USD vs DNB Telecom S

UBS Lux Equity Fund Biotech USD vs DNB Telecom S

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. DNB Telecom S

  • Security

    DNB Telecom S

  • Fee

    1.20%

  • ISIN

    NO0012740192

  • Holdings

    13

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with DNB Telecom S, we have 14 holdings where T-Mobile is the largest holding (9.47), followed by Deutsche Telekom (9.19) and KDDI Corp (7.51).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Telecom S.

UBS Lux Equity Fund Biotech USD DNB Telecom S
1. Regeneron Pharmaceuticals Inc
10.04 %
1. T-Mobile US Inc
USA
9.47 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Deutsche Telekom AG
Germany
9.19 %
3. Moderna Inc
9.21 %
3. KDDI Corp
Japan
7.51 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Verizon Communications Inc
USA
5.25 %
5. AbbVie Inc
USA
5.53 %
5. Rogers Communications Inc
4.86 %
6. Gilead Sciences Inc
USA
4.66 %
6. AT&T Inc
USA
4.52 %
7. Amgen Inc
4.3 %
7. Nokia Oyj
4.46 %
8. BioNTech SE
4.13 %
8. Nippon Telegraph & Telephone Corp
Japan
4.4 %
9. Karuna Therapeutics Inc
3.75 %
9. Telefónica SA
4.32 %
10. Royalty Pharma Plc
3.37 %
10. Elisa Oyj
Finland
4.19 %
- 11. Vodafone Group ADR
UK
3.86 %
- 12. Telenor ASA
Norway
3.69 %
- 13. SoftBank Corp
Japan
3.69 %

The list of fund holdings was last updated on June 5, 2025.